H
HealthEquity, Inc.
HQY · Healthcare
Q4 FY2026
Earning ended Jan 31, 2026Report generated Mar 18, 2026
The Float Engine Inside a Healthcare Wrapper the Market Keeps Mislabeling
Most investors are pricing this as a sleepy benefits-tech compounder, missing that the business has quietly become a custodial float machine whose earnings trajectory is now more correlated to the Fed than to hospital admissions — which cuts both ways, but currently prices in none of the upside from a structurally growing asset base that compounds for decades.
Flowly Score
Apr 16 Close
+83%$84.53
Fair Value
$155.00
75
Strongat $84.53
Business Strength7/10
The switching cost moat is genuine and compounding — migrating millions of HSA accounts with embedded investment elections and payroll integrations is an HR nightmare no benefits manager voluntarily engineers. The critical nuance is that this is now structurally a float business in healthcare clothing, which means the moat is real but the earnings are more rate-sensitive than the sector label implies.
Financial Resilience8/10
A Piotroski 9/9 is not an accident — OCF has exceeded net income every year, even through GAAP losses, and debt has collapsed by nearly the entire prior balance in a single year while buybacks accelerated. The capex cliff reveals a platform that has completed its heavy-build phase and is now throwing off cash with minimal reinvestment needs.
Growth & Trajectory7/10
The operating leverage story is real: earnings compounding far ahead of revenue while capex collapses is the signature of a fixed-cost platform that has crossed its inflection point. The 7 million bronze ACA enrollees and potential legislative HSA expansion represent genuine new-market optionality that most models treat as zero.
Valuation8/10at $79.40
A business with near-perfect financial health scores, a 6% FCF yield, and a pessimistic DCF scenario still embedding material upside is priced as though stagnation is the base case — that disconnect between price and fundamental trajectory is the opportunity. The market appears to be anchoring on the ugly historical P/E history without adjusting for the structural margin transformation that has already occurred.
Risk5/10
The interest rate cycle is not a tail risk — it is the central risk, and the earnings expansion that makes this business look so attractive was substantially rate-driven; a sustained cutting cycle compresses the float income that turbocharged recent FCF without a clear offset. The secondary threat is vertical integration: a large insurer with a captive bank subsidiary can bundle HSA administration into coverage at economics HealthEquity structurally cannot match.
The investment case rests on a straightforward mismatch: a capital-light recurring revenue platform with near-zero churn, a perfect financial health scorecard, and an FCF yield sitting well above where this quality of business normally trades. The margin transformation is not cyclical noise — it reflects a fixed-cost infrastructure finally being spread over a custodial asset base large enough to generate quasi-banking returns. When you strip out the amortization overhang from past acquisitions and normalize for the CapEx cliff that has already happened, the underlying earnings power of this business is meaningfully higher than what the income statement has historically shown, and the market appears to be using the wrong historical baseline. The trajectory from here is structurally supported in a way that separates this from a typical rate-cycle trade. HSA balances do not leave — they accumulate for decades, and the member acquired today at 30 is worth exponentially more to the business at 55. The potential expansion of HSA eligibility to bronze ACA enrollees would represent the first meaningful enlargement of the addressable market in a generation, layering new account growth onto a platform already generating strong returns on its existing base. The direct-to-consumer enrollment motion, if it achieves any scale, fundamentally changes the economics of customer acquisition by bypassing the employer intermediary entirely. The single biggest risk is not a competitor or a legislative shock — it is the Federal Reserve. The financial services revenue line, now the dominant bucket, is a levered bet on elevated short-term rates being sustained long enough for the growing asset base to offset yield compression. A faster-than-expected cutting cycle would expose just how much of recent earnings growth was rate-driven rather than structural, potentially resetting expectations sharply before the underlying account growth catches up. That is the bear case, and it is specific, quantifiable, and entirely outside management's control.